Beatrix Bartók
Gilead Sciences (United States)(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Rheumatoid Arthritis Research and Therapies, Chronic Myeloid Leukemia Treatments, Lymphoma Diagnosis and Treatment, Myeloproliferative Neoplasms: Diagnosis and Treatment
Most-Cited Works
- → Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis(2009)1,868 cited
- → Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy(2019)317 cited
- → Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial(2021)235 cited
- → Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial(2021)139 cited
- → PI3 Kinase δ Is a Key Regulator of Synoviocyte Function in Rheumatoid Arthritis(2012)108 cited
- → Post-transcriptional Regulation of the Yeast High Affinity Iron Transport System(2005)98 cited
- → Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 years(2021)79 cited
- → Phosphoinositide 3-Kinase δ Regulates Migration and Invasion of Synoviocytes in Rheumatoid Arthritis(2014)79 cited
- → PTPH1 Is a Predominant Protein-tyrosine Phosphatase Capable of Interacting with and Dephosphorylating the T Cell Receptor ζ Subunit(2004)69 cited
- → Integrative Omics Analysis of Rheumatoid Arthritis Identifies Non-Obvious Therapeutic Targets(2015)61 cited